Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Skin Diseases and Disorders01:23

Skin Diseases and Disorders

4.9K
Skin is the first line of defense and encounters a variety of microbes. Some pathogenic strains are often the cause of a broad range of infections of the skin and other body systems. These conditions can affect people of all ages and may have different causes, including genetic factors, infections, autoimmune reactions, environmental factors, and lifestyle choices.
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
4.9K
Fungal Phylum Microsporidia01:28

Fungal Phylum Microsporidia

266
Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
266
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

568
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
568
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

956
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
956
Chronic Obstructive Pulmonary Disease-I: Introduction01:20

Chronic Obstructive Pulmonary Disease-I: Introduction

3.3K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
3.3K
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

1.5K
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
1.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Enyzme immunoassay compared to immunodiffusion complement-fixation to assess the IgG serological response in coccidioidomycosis.

Medical mycology·2026
Same author

Cervical, Mediastinal, and Pericardial Disseminated Coccidioidomycosis: The Importance of Source Control.

Case reports in infectious diseases·2026
Same author

<i>Coccidioides</i> skin test performance and patterns of prior immunity to coccidioidomycosis among a large population of males entering California state prisons, 2015-2024: a population-based modelling study.

Lancet regional health. Americas·2026
Same author

Neglect of dimorphic fungi in community-acquired pneumonia guidelines.

American journal of respiratory and critical care medicine·2026
Same author

Development Framework of Desirability of Outcome Ranking Endpoints for Use in Clinical Trials of Invasive Fungal Diseases.

Open forum infectious diseases·2026
Same author

Blastomycosis, Histoplasmosis, and Coccidioidomycosis in Outpatient Community-Acquired Pneumonia.

JAMA network open·2026

Related Experiment Video

Updated: Nov 25, 2025

Application of I TASSER, trRosetta, UCSF Chimera, HADDOCK server, and HEX loria for De Novo and In Silico Design of Proteins
05:08

Application of I TASSER, trRosetta, UCSF Chimera, HADDOCK server, and HEX loria for De Novo and In Silico Design of Proteins

Published on: July 8, 2025

667

Coccidioidomycosis: Changing Concepts and Knowledge Gaps.

Neil M Ampel1

  • 1Department of Infectious Diseases, Medicine and Immunobiology University of Arizona, 1501 North Campbell Avenue, Tucson, AZ 85724, USA.

Journal of Fungi (Basel, Switzerland)
|December 16, 2020
PubMed
Summary

Coccidioidomycosis, a fungal infection, remains poorly understood despite its long history. This review covers new insights into its ecology, diagnosis, treatment, and potential vaccines, highlighting knowledge gaps.

Keywords:
Coccidioidesantifungalscoccidioidomycosisecologyvaccines

More Related Videos

Growing a Cystic Fibrosis-Relevant Polymicrobial Biofilm to Probe Community Phenotypes
03:53

Growing a Cystic Fibrosis-Relevant Polymicrobial Biofilm to Probe Community Phenotypes

Published on: April 19, 2024

899
Bio-energetics Investigation of Candida albicans Using Real-time Extracellular Flux Analysis
08:48

Bio-energetics Investigation of Candida albicans Using Real-time Extracellular Flux Analysis

Published on: March 19, 2019

7.2K

Related Experiment Videos

Last Updated: Nov 25, 2025

Application of I TASSER, trRosetta, UCSF Chimera, HADDOCK server, and HEX loria for De Novo and In Silico Design of Proteins
05:08

Application of I TASSER, trRosetta, UCSF Chimera, HADDOCK server, and HEX loria for De Novo and In Silico Design of Proteins

Published on: July 8, 2025

667
Growing a Cystic Fibrosis-Relevant Polymicrobial Biofilm to Probe Community Phenotypes
03:53

Growing a Cystic Fibrosis-Relevant Polymicrobial Biofilm to Probe Community Phenotypes

Published on: April 19, 2024

899
Bio-energetics Investigation of Candida albicans Using Real-time Extracellular Flux Analysis
08:48

Bio-energetics Investigation of Candida albicans Using Real-time Extracellular Flux Analysis

Published on: March 19, 2019

7.2K

Area of Science:

  • Medical Mycology
  • Infectious Diseases
  • Epidemiology

Background:

  • Coccidioidomycosis, endemic to the Americas, is caused by the fungus Coccidioides.
  • Despite over a century of study, significant knowledge gaps persist regarding this systemic fungal infection.
  • Understanding coccidioidomycosis is crucial due to its potential for severe morbidity and mortality.

Purpose of the Study:

  • To review recent advancements in understanding coccidioidomycosis.
  • To discuss evolving concepts in its ecology, epidemiology, and diagnosis.
  • To address current controversies in management and explore future directions like vaccine development.

Main Methods:

  • Literature review of recent research on coccidioidomycosis.
  • Synthesis of new information on ecological and epidemiological factors.
  • Analysis of diagnostic challenges and therapeutic controversies.

Main Results:

  • Emerging data is reshaping concepts of coccidioidomycosis's environmental and transmission dynamics.
  • Diagnostic tools show both limitations and promising advancements.
  • Management strategies remain debated, with ongoing research into novel therapeutics and prevention.

Conclusions:

  • Continued research is essential to fill critical knowledge gaps in coccidioidomycosis.
  • New ecological and epidemiological insights are crucial for public health strategies.
  • The development of effective diagnostics and a potential vaccine remains a priority.